FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/05/067547 [Registered on: 17/05/2024] Trial Registered Prospectively
Last Modified On: 15/05/2024
Post Graduate Thesis  Yes 
Type of Trial  Observational 
Type of Study   Cross Sectional Study 
Study Design  Other 
Public Title of Study   Pulmonary Hypertension and Chronic Kidney disease 
Scientific Title of Study   Prevalence of Pulmonary Hypertension in patients of Chronic Kidney Disease 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Nikhil Pantbalekundri 
Designation  PG student 
Affiliation  Jawaharlal Nehru Medical College, Sawangi- Meghe  
Address  Department of General Medicine, 3rd floor, Acharya Vinobha Bhave Rural Medical College, Sawangi- Meghe.

Wardha
MAHARASHTRA
442001
India 
Phone  9833595850  
Fax    
Email  nikhil6996pant@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr. Satish Mahajan 
Designation  Professor 
Affiliation  Department of Medicine, Jawaharlal Nehru Medical College, Sawangi- Meghe  
Address  Department of General Medicine, Acharya Vinobha Bhave Rural Medical College, Sawangi-Meghe

Wardha
MAHARASHTRA
442001
India 
Phone  9833595850  
Fax    
Email  mahajandr99@rediffmail.com  
 
Details of Contact Person
Public Query
 
Name  Nikhil Pantbalekundri 
Designation  PG student 
Affiliation  Jawaharlal Nehru Medical College, Sawangi- Meghe  
Address  At-Post Akol, Tal- Chikodi, Dist- Belgavi, Karnataka

Belgaum
KARNATAKA
591211
India 
Phone  9833595850  
Fax    
Email  nikhil6996pant@gmail.com  
 
Source of Monetary or Material Support  
Department of Medicine,3rd floor, Acharya Vinobha Bhave Rural Medical College, Sawangi-Meghe, Wardha, Maharashtra- 442001 
 
Primary Sponsor  
Name  Nikhil Pantbalekundri 
Address  Department of General Medicine, Jawaharlal Nehru Medical College, Sawangi- Meghe 
Type of Sponsor  Other [Self] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Nikhil Pantbalekundri  Acharya Vinobha Bhava Rural Hospital  Department of Medicine,3rd floor, Acharya Vinobha Bhave Rural Medical College, Sawangi-Meghe, Wardha, Maharashtra- 442001
Wardha
MAHARASHTRA 
9833595850

nikhil6996pant@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Datta Meghe Institute of Medical Sciences Institutional Ethics Committee  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: N189||Chronic kidney disease, unspecified, (2) ICD-10 Condition: N186||End stage renal disease, (3) ICD-10 Condition: N185||Chronic kidney disease, stage 5, (4) ICD-10 Condition: N184||Chronic kidney disease, stage 4 (severe), (5) ICD-10 Condition: N183||Chronic kidney disease, stage 3 (moderate), (6) ICD-10 Condition: N182||Chronic kidney disease, stage 2 (mild), (7) ICD-10 Condition: N181||Chronic kidney disease, stage 1,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Nil  Nil 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  99.00 Year(s)
Gender  Both 
Details  1) Newly Diagnosed CKD cases
2) Known cases of CKD on Conservative treatment
3) Known case of CKD on maintenance hemodialysis
4) Patients giving consent 
 
ExclusionCriteria 
Details  1) Not willing to Participate
2) Age less than 18years
3) Valvular heart disease
4) Congenital heart Disease
5) Pulmonary obstructive and restrictive diseases
6) HIV infected patients
7) Chronic liver disease
8) Connective tissue diseases
9) Hypothyroidism and Hyperthyroidism 
 
Method of Generating Random Sequence   Other 
Method of Concealment   Other 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
1) Statistically significant (p0.05) Prevalence of Pulmonary artery hypertension in patients of Chronic kidney disease (PASP 35 mmHg)
2) Prevalence is higher with higher grades of chronic kidney disease
2) Pulmonary artery hypertension can be used as an indicator for poor prognosis in end stage renal disease 
2 years 
 
Secondary Outcome  
Outcome  TimePoints 
strong association between diabetes & hypertension with PH (p less than 0.001)  8 days after admission 
 
Target Sample Size   Total Sample Size="126"
Sample Size from India="126" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   30/05/2024 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="2"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  

The history will be collected with special attention to CKD symptoms, congestive heart failure, PH, risk factors for developing CKD, concomitant diseases, and the length of time from CKD diagnosis. CKD, heart failure, and PH clinical symptoms were evaluated. Each case will be  investigated thoroughly. The Modification of Diet in Renal Disease formula will be used to measure the estimated glomerular filtration rate (eGFR). An electrocardiogram (ECG) will be performed to search for signs of PH, right ventricular (RV) strain pattern, left ventricular (LV) strain pattern, and ischemic heart disease (IHD). The pulmonary artery systolic pressure (PASP) will be computed using the Bernoulli equation and TR jet velocity in Doppler echocardiography. At rest, a PASP value of 35 mmHg is being considered suggestive of PH. Echocardiography will also used to assess the LV hypertrophy, dilatation, chamber size, LV systolic function and diastolic function, LV ejection fraction (EF), regional wall motion abnormality, and pericardial effusion. Comparison will be made between CKD patients with presence and absence of PH.

 
Close